Follow-up of musculoskeletal tumours. 2. Metastatic disease.
Both the prognosis and the morbidity of a patient with a primary malignant musculoskeletal tumour have improved over the past 25 years due to the advent of adjuvant chemotherapy and limb-sparing surgery. This has important implications for the role of imaging at the time of initial diagnosis and during follow-up. This pictorial essay reviews the imaging and pitfalls in the interpretation of musculoskeletal sarcoma metastases using a variety of radiological techniques. The optimal imaging strategy will be stressed.
Bearcroft
P W
PW
Department of Radiology, Addenbrooke's Hospital, Cambridge, UK.
Davies
A M
AM
D001859:Bone Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008279:Magnetic Resonance Imaging; D019042:Muscle Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D009362:Neoplasm Metastasis / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis; D012509:Sarcoma / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D014481:United States / Q000453:epidemiology